Preventix

Preventix is a Mexican biotech health company that develops a non-invasive blood-based cervical cancer screening test. The test analyzes protein biomarkers from a standard arm blood draw to detect early signals and precancerous lesions, is clinically validated with reported sensitivity above 94%, and is protected by national and international patents (reported in 153 countries). The technology is designed for accessible, scalable screening in low-resource and remote settings to expand preventive care and improve women’s health outcomes.